Thiago Carvalho @cyrilpedia@social.cleverlibre.org

#IDMastodon @Nature Prevalence of auto-Abs against type I IFN and ICU admission characteristics : auto-Abs against type I IFNs were found in at least 10% of critically ill #COVID19 patients
📌 https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-022-01095-5
📌 https://annalsofintensivecare.springeropen.com

A brilliant list of material (books, movies etc) hitting the #publicdomain as their 1927 copyright expires. The curated list by Jennifer Jenkins, Director of Duke’s Center for the Study of the Public Domain. https://web.law.duke.edu/cspd/publicdomainday/2023/

To degrade or not to degrade? That is the question answered by @haselbachlab in 2023's first video. Enjoy a mini lecture on #proteindegradation, #cryoEM, & #structuralbiology: 📺https://youtu.be/bU0UOJJBqH4

I lived in an almost entirely white world of science, never hearing voices like hers. @UNC colleagues and especially the folks who helped us start @CSS_Science began to open my eyes to the challenges my privilege shielded me from. Read this piece, and start listening. 2/2

Take the time today to read this powerful piece by @UChicago Physics PhD student Katrina Miller. We need to listen to stories like this, to even begin to understand the always uphill road some of our colleagues face 1/2 RT (thanks to Thiago for the pointer)
https://www.wired.com/story/the-unwritten-laws-of-physics/

#IDMastodon @Nature #ObstetricCriticalCare Clinical manifestations of #COVID19 in pregnant women between the Delta vs Omicron VOC periods. #SARSCoV2 vaccination was still effective in preventing severe #COVID19 in the Delta & Omicron VOC periods.
📌 https://www.sciencedirect.com/science/article/pii/S1341321X22002641
📌 https://www.sciencedirect.com/science/article/pii/S1341321X22002641
📌 https://www.sciencedirect.com/journal/journal-of-infection-and-chemotherapy/vol/29/issue/1

Reading backlog....a paper on the fate of retracted articles. The explosive dissemination of preprints during the pandemic has been impressive, and has really sped up the sharing of researsh findings tremendously. It also has open up " peer review" to the winder world.

New data: One of the few randomized controlled trials #RCT for the #treatment of #COVID19 shows effects for patients with #hematologic malignancies or #solidtumors with more immunological analyses upcoming! #Oncology #immunology #cancer
https://www.nature.com/articles/s43018-022-00503-w

@thescientist #Drugdevelopment From their humble beginnings preventing smallpox to boost #immuneresponses against #SARSCoV2, vaccines & their design, safety, efficacy.
📌 https://offers.the-scientist.com/hubfs/TS_PPL_Bio-Rad_Vaccine%20eBook_404943/44131_TS_Bio-Rad_vaccine_eBOOK_JL_V11.pdf?_ga=2.88221016.214789863.1672656454-1490875269.1671546712
📌https://www.bio-rad.com/webroot/web/pdf/lsr/literature/Bulletin_7464.pdf
📌 https://www.bio-rad.com/webroot/web/pdf/lsr/literature/Bulletin_7125.pdf

#lDMastodon @thelancet Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
📌 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00805-2/fulltext
📌 https://www.thelancet.com/journals/laninf/issue/current
📌 https://www.nejm.org/doi/full/10.1056/NEJMc2214302
📌 https://www.nejm.org/doi/full/10.1056/NEJMc2214293
📌https://journals.hh-publisher.com/index.php/pmmb/article/view/673/370